Fidaxomicin Tablet, Film Coated
Product Images NDC 60505-4833

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fidaxomicin (NDC 60505-4833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl-lbl-20s.jpg (Btl Lbl 20s)

This is a description of fidaxomicin tablets containing 200 mg each. The package includes 20 tablets, with storage instructions to keep them at 20°C to 25°C (68°F to 77°F). The manufacturer is Apotex Inc. in Toronto, Ontario, Canada, and they are distributed by Apotex Corp. in Weston, Florida. For dosage information, refer to the package insert.*

FDA Label Image

Ctn-lbl-20s.jpg (Ctn Lbl 20s)

This description provides details about Fidaxomicin Tablets containing 200 mg of fidaxomicin. The usual dosage and inactive ingredients are listed. It also includes storage instructions, manufacturer information, and caution to not accept if the seal over the bottle is broken. The package insert is mentioned for complete prescribing information.*

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.